Zydus Lifesciences Limited (ZYDUSLIFE.NS)
INR 868.85
(2.9%)
INR 868.85
(2.9%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 45.39 Billion INR | 71.91% |
| 2022 | 28.52 Billion INR | 15.31% |
| 2021 | 24.74 Billion INR | -9.56% |
| 2020 | 27.35 Billion INR | 30.16% |
| 2019 | 21.01 Billion INR | -12.15% |
| 2018 | 23.92 Billion INR | 4.02% |
| 2017 | 23 Billion INR | 49.75% |
| 2016 | 15.36 Billion INR | -26.32% |
| 2015 | 20.84 Billion INR | 40.02% |
| 2014 | 14.88 Billion INR | 47.34% |
| 2013 | 10.1 Billion INR | 6.22% |
| 2012 | 9.51 Billion INR | 57.79% |
| 2011 | 6.02 Billion INR | -33.92% |
| 2010 | 9.12 Billion INR | 32.12% |
| 2009 | 6.9 Billion INR | 34.25% |
| 2008 | 5.14 Billion INR | 41.4% |
| 2007 | 3.63 Billion INR | 22.82% |
| 2006 | 2.96 Billion INR | -4.39% |
| 2005 | 3.09 Billion INR | 64.96% |
| 2004 | 1.87 Billion INR | 1.46% |
| 2003 | 1.85 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 18.93 Billion INR | 19.75% |
| 2023 Q1 | 13.52 Billion INR | 21.33% |
| 2023 FY | 49.04 Billion INR | 71.91% |
| 2023 Q2 | 10.15 Billion INR | -24.89% |
| 2023 Q3 | 9.45 Billion INR | -6.95% |
| 2023 Q4 | 15.81 Billion INR | 67.31% |
| 2022 Q1 | 6.52 Billion INR | 36.32% |
| 2022 FY | 28.52 Billion INR | 15.31% |
| 2022 Q2 | 6.77 Billion INR | 3.92% |
| 2022 Q3 | 8.12 Billion INR | 19.91% |
| 2022 Q4 | 11.14 Billion INR | 37.14% |
| 2021 Q2 | 6.76 Billion INR | -9.9% |
| 2021 Q4 | 4.78 Billion INR | -15.95% |
| 2021 FY | 24.74 Billion INR | -9.56% |
| 2021 Q1 | 7.5 Billion INR | 10.86% |
| 2021 Q3 | 5.69 Billion INR | -15.78% |
| 2020 Q3 | 6.26 Billion INR | -8.46% |
| 2020 Q1 | 6.38 Billion INR | 2.34% |
| 2020 Q4 | 6.76 Billion INR | 8.03% |
| 2020 FY | 27.35 Billion INR | 30.16% |
| 2020 Q2 | 6.84 Billion INR | 7.17% |
| 2019 Q4 | 6.24 Billion INR | 20.21% |
| 2019 FY | 21.01 Billion INR | -12.15% |
| 2019 Q1 | 4.6 Billion INR | -22.39% |
| 2019 Q3 | 5.19 Billion INR | 14.52% |
| 2019 Q2 | 4.53 Billion INR | -1.54% |
| 2018 Q3 | 6.86 Billion INR | 27.0% |
| 2018 Q1 | 5.03 Billion INR | -30.73% |
| 2018 FY | 23.92 Billion INR | 4.02% |
| 2018 Q4 | 5.93 Billion INR | -13.55% |
| 2018 Q2 | 5.4 Billion INR | 7.37% |
| 2017 Q2 | 7.3 Billion INR | 370.32% |
| 2017 FY | 23 Billion INR | 49.75% |
| 2017 Q4 | 7.26 Billion INR | 4.68% |
| 2017 Q3 | 6.93 Billion INR | -5.0% |
| 2017 Q1 | 1.55 Billion INR | -55.51% |
| 2016 FY | 15.36 Billion INR | -26.32% |
| 2016 Q1 | 3.84 Billion INR | -18.91% |
| 2016 Q2 | 4.36 Billion INR | 13.59% |
| 2016 Q3 | 2.69 Billion INR | -38.22% |
| 2016 Q4 | 3.49 Billion INR | 29.49% |
| 2015 FY | 20.84 Billion INR | 40.02% |
| 2015 Q4 | 4.73 Billion INR | 7.54% |
| 2015 Q3 | 4.4 Billion INR | -9.36% |
| 2015 Q2 | 4.86 Billion INR | 14.03% |
| 2015 Q1 | 4.26 Billion INR | -18.86% |
| 2014 Q3 | 3.56 Billion INR | 12.19% |
| 2014 Q2 | 3.17 Billion INR | 9.95% |
| 2014 Q1 | 2.89 Billion INR | -26.18% |
| 2014 FY | 14.88 Billion INR | 47.34% |
| 2014 Q4 | 5.25 Billion INR | 47.34% |
| 2013 Q2 | 1.72 Billion INR | -22.37% |
| 2013 Q1 | 2.22 Billion INR | -9.15% |
| 2013 Q3 | 2.24 Billion INR | 30.35% |
| 2013 Q4 | 3.91 Billion INR | 74.19% |
| 2013 FY | 10.1 Billion INR | 6.22% |
| 2012 Q4 | 2.44 Billion INR | 19.06% |
| 2012 Q3 | 2.05 Billion INR | -73.24% |
| 2012 Q1 | 2.45 Billion INR | 408.97% |
| 2012 FY | 9.51 Billion INR | 57.79% |
| 2012 Q2 | 7.67 Billion INR | 213.02% |
| 2011 Q2 | 6.29 Billion INR | 0.0% |
| 2011 Q4 | -793.5 Million INR | -136.9% |
| 2011 Q3 | 2.15 Billion INR | -65.86% |
| 2011 FY | 6.02 Billion INR | -33.92% |
| 2010 FY | 9.12 Billion INR | 32.12% |
| 2009 FY | 6.9 Billion INR | 34.25% |
| 2008 FY | 5.14 Billion INR | 41.4% |
| 2007 FY | 3.63 Billion INR | 22.82% |
| 2006 FY | 2.96 Billion INR | -4.39% |
| 2005 FY | 3.09 Billion INR | 64.96% |
| 2004 FY | 1.87 Billion INR | 1.46% |
| 2003 FY | 1.85 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -688.316% |
| Hester Biosciences Limited | 364.77 Million INR | -12344.006% |
| Aarti Drugs Limited | 7.14 Billion INR | -534.967% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -1351.097% |
| Albert David Limited | 1.33 Billion INR | -3301.533% |
| Alembic Limited | 767.77 Million INR | -5812.187% |
| Alkem Laboratories Limited | 19.46 Billion INR | -133.235% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -18999.474% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -219652.13% |
| Brooks Laboratories Limited | -72.25 Million INR | 62924.558% |
| Eris Lifesciences Limited | 5.18 Billion INR | -776.003% |
| FDC Limited | 3.03 Billion INR | -1396.239% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -405.524% |
| Gufic Biosciences Limited | 2.89 Billion INR | -1468.593% |
| Hikal Limited | 1.49 Billion INR | -2937.88% |
| Ind-Swift Limited | 1.22 Billion INR | -3602.556% |
| Innova Captab Limited | 2.53 Billion INR | -1691.735% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -818.457% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -21107.251% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -774.774% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -2281.122% |
| Lupin Limited | 27.75 Billion INR | -63.527% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -165214.298% |
| Medico Remedies Limited | 277.11 Million INR | -16280.026% |
| Morepen Laboratories Limited | 4.17 Billion INR | -987.538% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -1066.713% |
| Orchid Pharma Limited | 2.36 Billion INR | -1822.512% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -1529.289% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1880.195% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -21717.832% |
| Sigachi Industries Limited | 1.47 Billion INR | -2979.729% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 1278.126% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -885.146% |
| Themis Medicare Limited | 1.3 Billion INR | -3383.372% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -721094.789% |
| Wanbury Limited | 1.7 Billion INR | -2558.846% |
| Windlas Biotech Limited | 1.29 Billion INR | -3394.676% |
| ZIM Laboratories Limited | 1.09 Billion INR | -4033.637% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -2159.395% |
| Ipca Laboratories Limited | 29.59 Billion INR | -53.369% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 56.481% |
| Venus Remedies Limited | 534.65 Million INR | -8390.024% |
| Sakar Healthcare Limited | 495.5 Million INR | -9060.737% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 56.564% |
| Divi's Laboratories Limited | 18.31 Billion INR | -147.908% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -914.596% |
| Mankind Pharma Limited | 40.86 Billion INR | -11.071% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | -1049.572% |
| Neuland Laboratories Limited | 5.31 Billion INR | -753.539% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -501.885% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -598.083% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -7209.183% |
| Wockhardt Limited | 140 Million INR | -32322.857% |
| Bal Pharma Limited | 214.56 Million INR | -21054.966% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 32.98% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -3587.406% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -8129.316% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -528.237% |
| Shilpa Medicare Limited | 3.76 Billion INR | -1106.73% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | -130.682% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -1603389.582% |
| Granules India Limited | 6.52 Billion INR | -595.315% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -18111.361% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -79.166% |
| NATCO Pharma Limited | 25.96 Billion INR | -74.84% |
| Suven Life Sciences Limited | -1.22 Billion INR | 3802.985% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -768.612% |
| Indoco Remedies Limited | 1.52 Billion INR | -2877.696% |
| Alpa Laboratories Limited | 61.51 Million INR | -73690.132% |
| Lasa Supergenerics Limited | -458 Million INR | 10010.809% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 1203.075% |